Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test
Open Access
- 26 April 2016
- journal article
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2016 (4) , 94-96
Abstract
Pulmonary involvement in Behçet's disease (BD) is uncommon; however, it is potentially fatal due to the risk of massive haemoptysis. We describe the case of a 36-year-old male presenting with a 2-month history of worsening dyspnoea, weight loss, haemoptysis, oral ulceration, erythema nodosum and superficial thrombophlebitis. He was diagnosed with pulmonary vasculitis secondary to BD; however, his symptoms were refractory to initial treatment with cyclophosphamide, azathioprine and prednisolone. We therefore trialled infliximab alongside methotrexate, which led to a remarkable improvement in his condition, enabling eventual discontinuation of prednisolone. Whilst not being one of the treatments currently recommended for managing pulmonary involvement in BD, infliximab has previously been successfully used in cases refractory to conventional therapy. We used the 6-min walk test (distance covered and lowest oxygen saturations) to monitor his progress, which correlated with his symptoms. This may represent a useful adjunct in monitoring the activity of pulmonary vasculitis.Keywords
This publication has 10 references indexed in Scilit:
- The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteriaJournal of the European Academy of Dermatology and Venereology, 2013
- Pulmonary Artery Involvement and Associated Lung Disease in Behçet DiseaseMedicine, 2012
- Resolution of Behçet's Syndrome Associated Pulmonary Arterial Aneurysms with InfliximabSeminars in Arthritis and Rheumatism, 2011
- Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report.2011
- Thrombosis and Behcet's syndrome in non-endemic regionsRheumatology, 2010
- Modification and validation of the Birmingham Vasculitis Activity Score (version 3)Annals of the Rheumatic Diseases, 2009
- EULAR recommendations for the management of Behçet diseaseAnnals of the Rheumatic Diseases, 2008
- Rare diseases bullet 12: Pulmonary manifestations of Behcet's diseaseThorax, 2001
- Behçet's disease: evaluation of a new instrument to measure clinical activityRheumatology, 1999
- VALIDATION OF THE INTERNATIONAL STUDY GROUP CRITERIA FOR BEHÇET'S DISEASERheumatology, 1994